Amount Raised
$15 Million
Round Type
Funding Round
BethesdaBiotechnologyHealthcareresearchDescription
Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of a $15 million financing on November 22, 2021, which brought the Company's cash reserves above $20 million.
Who else raised in Healthcare and research around the same time
Companies in the same sectors as Northwest Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Eikonoklastes Therapeutics raised $2.8M on January 13, 2022.
- Adolore Biotherapeutics raised $250K on January 13, 2022.
- Gameto raised $27M on January 11, 2022.
- Redcliffe Labs raised $47M on January 10, 2022.
- Gameto raised $23M (Funding Round) on January 10, 2022.
- Radicle Science raised $6M on January 7, 2022.
Who to call at Northwest Biotherapeutics, and when
A new round usually means Northwest Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Northwest Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Northwest Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Northwest Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Northwest Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Northwest Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.